IFNA1 and Burkitt lymphoma: Another group used mRNA electroporation to engineer moDCs to produce IL-15/IL-15Rα or IFN-α leading to increased NK cell activation and cytotoxic activity against Burkitt lymphoma cells in vitro (94, 95).